Germany not planning to take further biotech stakes after CureVac move - Scholz

Germany is not currently planning to take any further stakes in biotech firms, Finance Minister Olaf Scholz said on Wednesday after Berlin announced it would take a stake in German vaccine developer CureVac.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.